학술논문
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
Document Type
Article
Author
Source
In: European Journal of Haematology . (European Journal of Haematology, June 2024, 112(6):938-943)
Subject
Language
English
ISSN
16000609
09024441
09024441